101 related articles for article (PubMed ID: 16427643)
1. Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.
Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Chen MS; Crowe T; Loyd AB; Kapadia S; Nissen SE
Atherosclerosis; 2006 Nov; 189(1):229-35. PubMed ID: 16427643
[TBL] [Abstract][Full Text] [Related]
2. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
[TBL] [Abstract][Full Text] [Related]
3. Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study).
Nicholls SJ; Tuzcu EM; Schoenhagen P; Sipahi I; Crowe T; Kapadia S; Nissen SE
Am J Cardiol; 2005 Dec; 96(12):1636-9. PubMed ID: 16360349
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
[TBL] [Abstract][Full Text] [Related]
5. Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function.
Eshtehardi P; McDaniel MC; Dhawan SS; Binongo JN; Krishnan SK; Golub L; Corban MT; Raggi P; Quyyumi AA; Samady H
J Invasive Cardiol; 2012 Oct; 24(10):522-9. PubMed ID: 23043036
[TBL] [Abstract][Full Text] [Related]
6. Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial.
Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Ozduran V; Kapadia S; Nissen SE
Eur Heart J; 2006 Jul; 27(14):1664-70. PubMed ID: 16524891
[TBL] [Abstract][Full Text] [Related]
7. Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Crowe T; Kapadia S; Nissen SE
Am Heart J; 2006 Sep; 152(3):544-50. PubMed ID: 16923429
[TBL] [Abstract][Full Text] [Related]
8. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
Nissen SE
Am J Cardiol; 2005 Sep; 96(5A):61F-68F. PubMed ID: 16126025
[TBL] [Abstract][Full Text] [Related]
9. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
Brener SJ; Ivanc TB; Hu T
J Invasive Cardiol; 2008 Jun; 20(6):261-5. PubMed ID: 18523316
[TBL] [Abstract][Full Text] [Related]
10. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
Choi SH; Chae A; Miller E; Messig M; Ntanios F; DeMaria AN; Nissen SE; Witztum JL; Tsimikas S
J Am Coll Cardiol; 2008 Jul; 52(1):24-32. PubMed ID: 18582631
[TBL] [Abstract][Full Text] [Related]
11. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.
Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE
Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944
[TBL] [Abstract][Full Text] [Related]
12. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
Shukla A; Sharma MK; Jain A; Goel PK
Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
[TBL] [Abstract][Full Text] [Related]
13. Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis.
Clementi F; Di Luozzo M; Mango R; Luciani G; Trivisonno A; Pizzuto F; Martuscelli E; Mehta JL; Romeo F
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):231-7. PubMed ID: 19262209
[TBL] [Abstract][Full Text] [Related]
14. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
[TBL] [Abstract][Full Text] [Related]
15. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study).
Nicholls SJ; Tuzcu EM; Sipahi I; Schoenhagen P; Hazen SL; Ntanios F; Wun CC; Nissen SE
Am J Cardiol; 2006 Jun; 97(11):1553-7. PubMed ID: 16728212
[TBL] [Abstract][Full Text] [Related]
16. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
Einecke D
MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
[No Abstract] [Full Text] [Related]
17. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
Berry C; L'Allier PL; Grégoire J; Lespérance J; Levesque S; Ibrahim R; Tardif JC
Circulation; 2007 Apr; 115(14):1851-7. PubMed ID: 17389269
[TBL] [Abstract][Full Text] [Related]
18. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano.
Nicholls SJ; Tuzcu EM; Sipahi I; Schoenhagen P; Crowe T; Kapadia S; Nissen SE
J Am Coll Cardiol; 2006 Mar; 47(5):992-7. PubMed ID: 16516083
[TBL] [Abstract][Full Text] [Related]
19. Effect of torcetrapib on the progression of coronary atherosclerosis.
Nissen SE; Tardif JC; Nicholls SJ; Revkin JH; Shear CL; Duggan WT; Ruzyllo W; Bachinsky WB; Lasala GP; Tuzcu EM;
N Engl J Med; 2007 Mar; 356(13):1304-16. PubMed ID: 17387129
[TBL] [Abstract][Full Text] [Related]
20. Remodeling index compared to actual vascular remodeling in atherosclerotic left main coronary arteries as assessed with long-term (> or =12 months) serial intravascular ultrasound.
von Birgelen C; Hartmann M; Mintz GS; Böse D; Eggebrecht H; Neumann T; Gössl M; Wieneke H; Schmermund A; Stoel MG; Verhorst PM; Erbel R
J Am Coll Cardiol; 2006 Apr; 47(7):1363-8. PubMed ID: 16580523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
